As of April 3, 2026, Bionano Genomics Inc. (BNGO) is trading at $1.2 per share, posting a modest 0.84% gain on the day. The life sciences firm, which focuses on genomic analysis tools for research and clinical applications, has traded in a relatively tight range in recent weeks, with clear technical levels emerging as key markers for market participants to monitor. No recent earnings data is available for BNGO as of this analysis, so trading action has been largely driven by technical dynamics a
BNGO Stock Analysis: Bionano Genomics Inc. holds 1.2 level with mild daily gain in genomics sector
BNGO - Stock Analysis
4556 Comments
1742 Likes
1
Aritzi
Community Member
2 hours ago
Real-time US stock market capitalization analysis and size classification for appropriate risk assessment and position sizing decisions. We help you understand how company size impacts volatility and expected returns in different market conditions and economic environments. We provide size analysis, volatility by market cap, and size factor returns for comprehensive coverage. Understand size impact with our comprehensive capitalization analysis and size classification tools for risk management.
👍 286
Reply
2
Roche
Loyal User
5 hours ago
US stock momentum indicators and trend analysis strategies for capturing strong directional moves in the market. Our momentum research identifies stocks that are showing the strongest price appreciation and fundamental improvement.
👍 13
Reply
3
Xao
Experienced Member
1 day ago
I don’t know why, but this feels urgent.
👍 30
Reply
4
Daresha
Legendary User
1 day ago
I should’ve double-checked before acting.
👍 165
Reply
5
Serianna
Expert Member
2 days ago
Expert US stock balance sheet health analysis and debt sustainability metrics to assess financial stability and long-term risk for portfolio companies. Our fundamental analysis digs deep into financial statements to identify hidden risks that might not be obvious from headline numbers alone. We provide debt analysis, liquidity metrics, and solvency indicators for comprehensive financial health assessment. Understand balance sheet health with our comprehensive fundamental analysis and risk metrics for safer investing.
👍 192
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.